REVVITY INC (RVTY)

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Thursday to uncover the stocks that are gapping in the S&P500 index.

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.

Revvity to Present at Goldman Sachs Global Healthcare Conference

Commit To Buy Revvity At $105, Earn 10% Annualized Using Options

RVTY Makes Bullish Cross Above Critical Moving Average

RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024

RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Revvity Announces Financial Results for the First Quarter of 2024

Revvity Board Declares Quarterly Dividend

Revvity to Present at BofA Securities 2024 Health Care Conference

Revvity Unveils a New Era of Automated Tuberculosis Testing

Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

Revvity (RVTY) Shares Cross Above 200 DMA

Revvity Now #441 Largest Company, Surpassing J.M. Smucker

Revvity To Hold Earnings Call on Monday, April 29, 2024

Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software

Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

Bullish Two Hundred Day Moving Average Cross - RVTY

Revvity to Present at Upcoming Investor Conferences

Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions

Friday Sector Laggards: Utilities, Healthcare

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023

Revvity (RVTY) Shares Cross Above 200 DMA

Revvity Board Declares Quarterly Dividend

Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors

Bullish Two Hundred Day Moving Average Cross - RVTY

Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance

Thursday Sector Leaders: Healthcare, Financial

Revvity to Present at J.P. Morgan Healthcare Conference

Funds Added To RVTY Positions

Wednesday Sector Leaders: Utilities, Healthcare

NYSE: RVTY Investor Notice: Investigation over Possible Securities Laws Violations by Revvity, Inc.

San Diego, CA -- (SBWIRE) -- 12/11/2023 -- Revvity, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Neurocrine Biosciences Larger Than S&P 500 Component Revvity

Revvity to Present at Annual Evercore ISI HealthCONx Conference